Insider buying last 90 days
No open-market insider purchases were filed for G in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every G insider filing, plotted on the chart in Gekko.Open G in Gekko
Gekko Brief
AI summaryGenpact has been described this week as a strong value stock, with coverage also offering a general overview of its price and history and separate headlines carrying a positive tone. Beyond that framing, no specific results, guidance, deal or regulatory development is cited.
Genpact trades at $32.60, down 1.5% on the day and below both its 50-day average of $34.91 and 200-day average of $36.84, with the 50-day also below the 200-day, reflecting a broader trend that has taken the stock down 13.1% over one month and 22% over the past year, though it remains up 17.1% over three months. The GekkoIndex reads 66.9, placing Genpact in the Accumulation zone. Against a Gekko Fair Value of $56.22, the current price sits 42% below that level.
Genpact's next earnings report is scheduled for 5 November 2026 after the close, 37 days away and outside a typical 20-trading-day holding window; its last report on 6 August 2026 produced a $1.00 EPS actual against a $0.97 estimate, with a -2.8% reaction. No insider, Congress or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality from this point has averaged -1.1% over the next 20 trading days across 5 years, rising in 2 of them. Analyst coverage shows 3 buy and 7 hold ratings among 10 firms, with a consensus target of $42.18.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Genpact price vs fair value
Close $32.60200-day averageGekko Fair Value $56.22
Genpact quick facts
- Market cap
- $5.53B
- P/E ratio
- 9.9
- Forward P/E
- 18.3
- EPS, TTM
- $3.36
- Revenue, TTM
- $5.25B
- Profit margin
- 11.1%
- Dividend yield
- 2.14%
- Beta
- 0.59
- Volume
- 1.36M avg 1.95M
- 1-year return
- −22.0%
- Typical daily move
- ±3%
- Typical 20-day move
- ±5.2%
- 50-day average
- $34.91
- 200-day average
- $36.84
- Next earnings
- Nov 5 after close
- Shares outstanding
- 168.0M
Genpact swing-trade checklist
Genpact scores 3 supportive, 0 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive0 mixed2 headwinds
- Trendheadwind
Below 50 and 200-day
Close $32.60 is below the 50-day ($34.91) and 200-day ($36.84) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexsupportive
66.9, Accumulation
Reading 66.9 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
42.0% below
Price is 42% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 37 days
Next report Nov 5, 2026, 37 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−1.1% on average
From this point in the calendar, the next 20 trading days averaged −1.1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Genpact stock chart and price history
Genpact closed at $32.60 on Sep 28, 2026, −22.0% over the past year, inside a 52-week range of $26.85 to $48.64.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −13.1%
- 3 months
- +17.1%
- 6 months
- −10.9%
- 1 year
- −22.0%
The full G chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open G in Gekko
Follow Genpact through every session
Put G on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track G in GekkoFree for 7 days. No credit card required.
Genpact GekkoIndex: the smart money zone
Genpact’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 66.9, in the Accumulation zone, up 2.8 points over five sessions.
66.9Accumulation
Up 2.8 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 46 | +1.3% | +3.3% | ||
| Accumulation (current zone) | 267 | +0.2% | +0.7% | ||
| Neutral | 307 | −0.3% | −0.1% | ||
| Distribution | 45 | +1.0% | +0.1% | ||
| Selling | 7 | Too few readings yet | |||
Average G share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the G price, zone by zone.Track G in Gekko
Is Genpact stock overvalued? Gekko Fair Value
Genpact trades 42.0% below Gekko Fair Value of $56.22, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Genpact shares are worth, recalculated every trading day.
$56.22
Gekko Fair Value, Sep 29, 2026
42.0% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open G in Gekko
Genpact insider and Congress trading
No open-market insider purchases were filed for Genpact, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in G were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for G, plotted on the chart in Gekko.Open G in Gekko
Buybacks
Genpact has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $50.02M
- As a share of market cap
- 0.91%
- Trailing four quarters
- $310.1M
From company filings.
Genpact earnings: next date and track record
Genpact reports on Nov 5, 2026, after the close (37 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected after the close, 37 days away
- EPS estimate
- $1.04
- Revenue estimate
- $1.38B
8 of 8reports beat the EPS estimate
±8.7%average move across the report
5 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $1.00 est $0.97 | $1.34B est $1.33B | −2.8% |
| May 7, 2026 | $0.98 est $0.92 | $1.30B est $1.29B | −3.7% |
| Feb 5, 2026 | $0.97 est $0.94 | $1.32B est $1.31B | +5.3% |
| Nov 6, 2025 | $0.97 est $0.90 | $1.29B est $1.27B | +14.6% |
| Aug 7, 2025 | $0.88 est $0.85 | $1.25B est $1.26B | +3.2% |
| May 7, 2025 | $0.84 est $0.80 | $1.21B est $1.21B | −15.4% |
| Feb 6, 2025 | $0.91 est $0.86 | $1.25B est $1.23B | +11.2% |
| Nov 7, 2024 | $0.85 est $0.80 | $1.21B est $1.19B | +13.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Genpact stock forecast and analyst price targets
Analysts’ average 12-month price target for Genpact is $42.18, +29.4% from the last close, from 10 firms rating the stock in the last 90 days.
$42.18consensus 12-month target, +29.4% from the last close
Now $32.60Avg $42.18
Low $31High $45
Each firm’s latest rating in the last 90 days: 10 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 13 | Citi | $36 | +10.4% |
| Sep 8 | William Blair | — | — |
| Aug 11 | Mizuho Securities | $39 | +19.6% |
| Aug 10 | J.P. Morgan | $45 | +38.0% |
| Aug 10 | Citi | $36 | +10.4% |
+0.7%average 20-day move after past Accumulation readings
−1.1%average move over the next 20 trading days in the last 5 years
±3%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Genpact seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Genpact averaged −1.1% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.4% | 2 of 5 |
| Next 10 trading days | −1.1% | 3 of 5 |
| Next 15 trading days | +0.2% | 3 of 5 |
| Next 20 trading days | −1.1% | 2 of 5 |
| Next 30 trading days | +4.2% | 4 of 5 |
For scale, G’s typical 20-trading-day move in either direction is about 5.2%.
Genpact market cap and key statistics
Genpact’s market cap is $5.53B, with a P/E ratio of 9.9 and revenue of $5.25B over the last twelve months.
Valuation
- Market cap
- $5.53B
- P/E ratio
- 9.9
- Forward P/E
- 18.3
- EPS, TTM
- $3.36
- Gekko Fair Value
- $56.22
Trading
- Volume
- 1.36M
- Avg volume, 20 days
- 1.95M
- 52-week high
- $48.64
- 52-week low
- $26.85
- Shares outstanding
- 168.0M
Financials
- Revenue, TTM
- $5.25B
- Profit margin
- 11.1%
- Return on equity
- 22.5%
- Quarterly earnings growth, YoY
- +14.7%
Risk and income
- Beta
- 0.59
- Typical daily move
- ±3%
- Typical 20-day move
- ±5.2%
- Dividend yield
- 2.14%
Genpact stock news this week
3 headlines about Genpact from the past week, newest first, each linking to the publisher.
- Here's Why Genpact (G) is a Strong Value StockZacks Investment Research, Sep 23
- Genpact Limited (G) stock price, news, quote and historyYahoo Finance Australia, Sep 23
- Genpact Limited (G) latest stock news and headlines – Yahoo FinanceYahoo Finance Singapore, Sep 22
Genpact peers
Genpact’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| SHOPShopify | Neutral | 5.0% above |
| CTASCintas | Neutral | 11.5% above |
| PYPLPayPal | Accumulation | 4.6% below |
| XYZBlock | Accumulation | 2.5% above |
| CPAYCorpay | Accumulation | 18.1% below |
| FISVFiserv | Buying | 40.6% below |
A peer links to its own page where one exists.
Genpact stock FAQ
What is Genpact’s market cap?
Genpact’s market cap is $5.53B at the Sep 28, 2026 close of $32.60, with 168.0M shares outstanding. The shares trade on a P/E ratio of 9.9.
What is the Genpact stock forecast?
The consensus analyst 12-month price target for Genpact is $42.18, +29.4% from the last close. Of the 10 firms that rated the stock in the last 90 days, 3 rate it a buy, 7 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Genpact stock overvalued or undervalued?
On Gekko’s estimate Genpact is undervalued: the Sep 28, 2026 close of $32.60 is 42.0% below Gekko Fair Value of $56.22. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Genpact report earnings next?
Genpact is expected to report on Nov 5, 2026, after the market closes (37 days away). Analysts expect earnings of $1.04 per share on revenue of $1.38B. Genpact beat the earnings estimate in 8 of its last 8 reports, moving 8.7% on average across the report.
What is Genpact’s 52-week high and low?
Genpact’s 52-week high is $48.64 and its 52-week low is $26.85; it closed at $32.60 on Sep 28, 2026, −22.0% over the past year. Over the last five years the shares peaked at $56.76 on Feb 7, 2025.
Is Genpact stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk) and 2 as headwinds (trend and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Genpact the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.